{{Rsnum
|rsid=33948578
|Chromosome=11
|Orientation=minus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=HBB
|position=5226794
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=HBB
}}{{omim
|id=141900
|rsnum=33948578
|variant=0044
}}
{{omim
|id=141900
|rsnum=33948578
|variant=0218
}}
{{omim
|id=141900
|rsnum=33948578
|variant=0444
}}{{ClinVar
|rsid=33948578
|Reversed=1
|FwdREF=T
|FwdALT=A,C,G
|REF=A
|ALT=C,G,T
|RSPOS=5248024
|CHROM=11
|dbSNPBuildID=126
|SSR=0
|SAO=1
|VP=0x050368000000000002110104
|GENEINFO=HBB:3043
|GENE_NAME=HBB
|GENE_ID=3043
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000011.9:g.5248024A>C; NC_000011.9:g.5248024A>G; NC_000011.9:g.5248024A>T
|CLNORIGIN=1
|CLNSRCID=
294; 141900.0044; 293; 141900.0218; 2542; 141900.0444; 141900.0452
|CLNSIG=255
|CLNCUI=
|CLNACC=
RCV000016295.1; RCV000016546.1; RCV000016547.1; RCV000016548.1; RCV000016807.1
|Tags=RV;PM;PMC;S3D;SLO;OTHERKG;LSD;OM;NOV
|CLNDBN=HEMOGLOBIN CASTILLA; HEMOGLOBIN PERTH; HEMOGLOBIN ABRAHAM LINCOLN; HEMOGLOBIN KOBE; HEMOGLOBIN MEDICINE LAKE
|CLNSRC=HBVAR; OMIM Allelic Variant
|Disease=HEMOGLOBIN CASTILLA; HEMOGLOBIN PERTH; HEMOGLOBIN ABRAHAM LINCOLN; HEMOGLOBIN KOBE; HEMOGLOBIN MEDICINE LAKE
}}{{PMID Auto
|PMID=402773
|Title=Congenital Heinz body haemolytic anaemia due to haemoglobin Perth in a Nama child seemingly aggravated by the high nitrate content of the water supply.
}}

{{PMID Auto
|PMID=4127713
|Title=Haemoglobin Perth: beta-32 (B14) Leu leads to Pro, an unstable haemoglobin causing haemolysis.
}}

{{PMID Auto
|PMID=4352462
|Title=Hemoglobin Abraham Lincoln, beta32 (B14) leucine leads to proline. An unstable variant producing severe hemolytic disease.
|OA=1
}}

{{PMID Auto
|PMID=11939520
|Title=Unstable Hb Perth in a Taiwanese subject: a T-->C substitution at codon 32 of the beta-globin gene creates an MspI site.
}}

{{PMID Auto
|PMID=14649317
|Title=Hb Castilla [beta32(B14)Leu --> Arg] caused by a de novo mutation.
}}

{{PMID Auto
|PMID=7660732
|Title=Morphohistochemical relationships between adrenal cortex and major salivary glands in response to chronic suramin treatment.
}}